GlassScriptPhysician profile
Loyrirk Temiyakarn
NPI 1285952572
$5,136.51
in general payments reported to CMS, 2019-2025
13 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,690 · 2020: $942 · 2021: $158 · 2022: $366 · 2023: $375 · 2024: $381 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,021.26 | 2019-2025 | Indigo System |
| Bard Peripheral Vascular, INC. | $1,072.81 | 2019 | |
| Argon Medical Devices, INC. | $928.35 | 2019-2020 | |
| Inari Medical, INC. | $558.02 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $214.29 | 2022-2025 | Concertotm, In.Pact Admiral, Mvp |
| Biocompatibles, INC. | $142.90 | 2019 | |
| Boston Scientific Corporation | $40.52 | 2021-2022 | |
| Medtronic Vascular, INC. | $35.57 | 2019-2020 | |
| Cook Medical LLC | $35.20 | 2020-2024 | Rosch-Uchida |
| Angiodynamics, INC. | $24.67 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.21 | 2020 | |
| Terumo Medical Corporation | $21.19 | 2022 | |
| Becton, Dickinson and Company | $20.52 | 2024 | Pristine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loyrirk Temiyakarn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.